Side-by-Side Wegovy vs Mounjaro Analysis & UK Pricing
Understanding Whether Wegovy or Mounjaro Better Fits Your Treatment Goals
The fundamental difference between Wegovy and Mounjaro lies in their mechanisms of action, which may influence which treatment proves wegovy or mounjaro better for individual patients. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural satiety hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual-action approach means Mounjaro works through two complementary pathways to regulate appetite and glucose metabolism, potentially offering different benefits for patients with varying metabolic profiles.
When considering wegovy or mounjaro better suited to your circumstances, the dosing schedules also differ significantly. Wegovy follows a 5-dose escalation from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro uses 6 doses ranging from 2.5mg to 15mg with a different titration schedule. Both are prescription-only medicines requiring clinical assessment, but the choice between them depends on factors including your medical history, lifestyle preferences, and how your body responds to different receptor mechanisms. At EverydayMeds, our prescribers can guide you through this decision based on your individual clinical profile.
Wegovy vs Mounjaro Pricing Comparison and Value Assessment
Determining wegovy or mounjaro better value requires understanding the complete cost structure for each treatment pathway. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). Our bundle options provide convenience with the Intro Duo (0.25mg & 0.5mg) at £169.99, or the Ultimate Stability Trio offering three months of 2.4mg maintenance doses for £649.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these prices.
Mounjaro pricing follows a different structure reflecting its distinct dosing regimen, though both treatments are available through the same streamlined EverydayMeds service. When evaluating wegovy or mounjaro better financial fit, consider not just individual pen costs but the complete treatment journey including dose escalation phases. Our bundle pricing offers convenience benefits including Reliable Supply continuity, fewer separate orders, and single temperature-controlled deliveries. Both treatments represent significant investments in long-term weight management, but the choice should primarily be guided by clinical suitability rather than cost alone.
Clinical Evidence: Wegovy vs Mounjaro Trial Data
Clinical trials provide essential context when determining wegovy or mounjaro better evidence base, though direct head-to-head comparisons are limited due to different study designs and populations. Wegovy's evidence comes primarily from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The STEP programme also demonstrated cardiovascular benefits, with the SELECT trial showing a 20% reduction in major cardiovascular events.
Mounjaro's clinical evidence derives from the SURMOUNT trials, which evaluated tirzepatide's dual-receptor approach in weight management settings. When considering wegovy or mounjaro better supported by research, both demonstrate substantial efficacy, but the different mechanisms and trial designs make direct percentage comparisons inappropriate. Both treatments showed their effects alongside reduced-calorie diets and increased physical activity, emphasising that neither medication works in isolation. Your prescriber can help interpret which evidence base aligns better with your medical profile and treatment objectives.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy's mechanism helps clarify when wegovy or mounjaro better suits different metabolic profiles. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This hormone signals to your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety after smaller portions. Additionally, GLP-1 receptor activation influences glucose metabolism, though Wegovy is specifically licensed for weight management rather than diabetes treatment. This focused GLP-1 approach provides a well-established pathway for appetite regulation, supported by extensive clinical experience across the semaglutide family of medications.
EverydayMeds Ordering Process for Both Treatments
Whether you determine wegovy or mounjaro better suits your needs, EverydayMeds streamlines access to both treatments through our comprehensive service. The process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals, allowing our prescribers to evaluate suitability for either treatment. Standard prescriber review typically takes 3 working days, with express 24-hour review available for urgent requirements. Once approved, both Wegovy and Mounjaro are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all supplies meet UK regulatory standards, with full patient support throughout your treatment journey. This unified approach means you can access either treatment through one trusted provider, with seamless switching between options if clinically appropriate.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical factors often influence whether wegovy or mounjaro better fits your lifestyle, with storage requirements being particularly relevant for frequent travellers. Wegovy offers superior storage flexibility, remaining stable for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater travel convenience and reduces refrigeration anxiety. Wegovy uses Novo Nordisk's FlexTouch pen system, which many patients find intuitive for once-weekly injections, whilst Mounjaro employs its own pre-filled pen design. Both treatments follow mandatory dose escalation schedules that cannot be rushed, requiring patience during the initial titration phases. The injection technique and pen operation differ slightly between treatments, though both are designed for patient self-administration with minimal training required.
Individual Response Factors: Which Treatment Mechanism Suits You
Determining wegovy or mounjaro better for your specific situation requires understanding individual response patterns to different receptor mechanisms. Some patients respond more favourably to Wegovy's focused GLP-1 approach, particularly those whose primary challenge is appetite control and portion size management. The single-receptor mechanism provides predictable effects for many patients, with extensive real-world experience informing prescriber decisions.
Conversely, patients with more complex metabolic profiles might find wegovy or mounjaro better addressed through Mounjaro's dual GIP and GLP-1 receptor activation. This dual approach potentially offers benefits for patients who need broader metabolic support beyond appetite regulation alone. However, individual response varies significantly, and some patients who don't achieve desired results with one treatment may succeed with the alternative. Your EverydayMeds prescriber can help predict likely responses based on your medical history, though treatment selection sometimes involves clinical trial to determine optimal fit.
Making Your Decision: Professional Guidance and Next Steps
Rather than definitively answering wegovy or mounjaro better, the optimal choice depends on your individual medical profile, lifestyle factors, and treatment preferences. Both treatments are available through EverydayMeds, ensuring continuity of care regardless of your choice, with the option to switch treatments if clinically appropriate. New customers can start their journey using discount code FIRST40 at checkout, whilst our clinical team provides ongoing support throughout your treatment experience. Consider booking a consultation to discuss which treatment aligns better with your circumstances, medical history, and weight management objectives. Our prescribers have extensive experience with both medications and can provide personalised guidance based on current clinical evidence and your individual needs. Take the first step by completing our online assessment at https://everydaymeds.co.uk/collections/weight-loss, where both Wegovy and Mounjaro options are available with professional clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
